LGT Capital Partners LTD. Acquires 190,950 Shares of Teleflex Incorporated (NYSE:TFX)

LGT Capital Partners LTD. boosted its position in Teleflex Incorporated (NYSE:TFX) by 285.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 257,864 shares of the medical technology company’s stock after purchasing an additional 190,950 shares during the quarter. Teleflex comprises 1.9% of LGT Capital Partners LTD.’s portfolio, making the stock its 18th biggest holding. LGT Capital Partners LTD.’s holdings in Teleflex were worth $64,296,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. lifted its stake in shares of Teleflex by 2.5% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 2,231 shares of the medical technology company’s stock worth $792,000 after acquiring an additional 54 shares during the period. HighTower Advisors LLC grew its stake in shares of Teleflex by 2.2% in the 1st quarter. HighTower Advisors LLC now owns 4,678 shares of the medical technology company’s stock valued at $1,655,000 after buying an additional 99 shares during the period. Private Advisor Group LLC acquired a new position in shares of Teleflex during the first quarter worth approximately $455,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of Teleflex by 6.6% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,268 shares of the medical technology company’s stock worth $2,224,000 after acquiring an additional 388 shares in the last quarter. Finally, Yousif Capital Management LLC lifted its holdings in shares of Teleflex by 2.7% in the first quarter. Yousif Capital Management LLC now owns 7,158 shares of the medical technology company’s stock valued at $2,540,000 after purchasing an additional 190 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on TFX. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Truist Financial cut their target price on shares of Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a research report on Friday, February 23rd. Royal Bank of Canada reduced their target price on Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. Raymond James increased their price target on shares of Teleflex from $227.00 to $271.00 and gave the stock an “outperform” rating in a report on Wednesday, December 20th. Finally, Morgan Stanley upgraded shares of Teleflex from an “equal weight” rating to an “overweight” rating and set a $261.00 price target for the company in a research report on Monday, December 4th. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Teleflex presently has a consensus rating of “Moderate Buy” and a consensus target price of $265.56.

Insider Buying and Selling at Teleflex

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the completion of the sale, the vice president now owns 10,050 shares of the company’s stock, valued at $2,261,250. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.41% of the company’s stock.

Teleflex Trading Up 1.0 %

TFX opened at $226.17 on Friday. The company has a quick ratio of 1.29, a current ratio of 2.32 and a debt-to-equity ratio of 0.39. The stock has a market cap of $10.64 billion, a PE ratio of 30.04, a PEG ratio of 2.14 and a beta of 1.11. The business has a 50 day moving average of $236.16 and a 200-day moving average of $224.08. Teleflex Incorporated has a 52 week low of $177.63 and a 52 week high of $276.43.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.26 by $0.12. The company had revenue of $773.90 million for the quarter, compared to analysts’ expectations of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. Teleflex’s revenue was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.52 EPS. Equities research analysts predict that Teleflex Incorporated will post 13.73 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date was Thursday, February 29th. Teleflex’s dividend payout ratio (DPR) is presently 18.06%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.